Anzeige
Mehr »
Donnerstag, 09.10.2025 - Börsentäglich über 12.000 News
Defence-Aktie mit Ritterschlag: Regierungs-Einladung zur größten Militärmesse
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40UCN | ISIN: CA4576377002 | Ticker-Symbol: MWG
Tradegate
08.10.25 | 13:57
1,900 Euro
-9,52 % -0,200
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
INMED PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
INMED PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,0402,12008.10.
2,0802,16008.10.

Aktuelle News zur INMED PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
23.09.InMed Pharmaceuticals Inc. - 8-K, Current Report3
INMED PHARMACEUTICALS Aktie jetzt für 0€ handeln
23.09.InMed Pharmaceuticals GAAP EPS of -$8.36, revenue of $4.94M5
23.09.InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update187Advances INM-901 program, addressing multiple key biological pathways implicated in Alzheimer's disease pathologyFurther develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related...
► Artikel lesen
06.09.InMed Pharmaceuticals Inc. - 8-K, Current Report-
05.09.InMed Pharmaceuticals: InMed to Participate in the H.C. Wainwright 27th Annual Global Investment Conference437Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of...
► Artikel lesen
28.07.InMed Pharmaceuticals Inc. - 8-K, Current Report-
28.07.InMed Pharmaceuticals: InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025249Vancouver, British Columbia--(Newsfile Corp. - July 28, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...
► Artikel lesen
09.07.InMed Pharmaceuticals registers 3.9M shares for resale2
09.07.InMed Pharmaceuticals Inc. - S-1, General form for registration of securities1
27.06.InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules297Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...
► Artikel lesen
25.06.InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules237Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...
► Artikel lesen
24.06.InMed Pharmaceuticals Inc. - 8-K, Current Report2
24.06.InMed stock soars after promising Alzheimer's drug preclinical results5
24.06.Why InMed's Alzheimer's Drug Candidate Is Fueling Sudden Stock Surge3
24.06.InMed's Alzheimer's drug candidate shows reduced inflammation in lab tests12
24.06.InMed Pharmaceuticals: InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study333Demonstrates statistically significant reduction of pro-inflammatory cytokines, including IL-6, IL-1ß, IL-2, and KC/GroSignificantly reduces levels of inflammasome marker, NLRP3, a key contributor...
► Artikel lesen
13.06.InMed Pharmaceuticals: InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA1.001Vancouver, British Columbia--(Newsfile Corp. - June 13, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...
► Artikel lesen
13.06.InMed Pharmaceuticals Inc. - 8-K, Current Report1
13.05.InMed Pharmaceuticals Inc. - 8-K, Current Report6
13.05.InMed Pharmaceuticals Non-GAAP EPS of -$1.94, revenue of $1.26M4
Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1